An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection (Q73357670)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 1997

Language	Label	Description	Also known as
English	An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection	scientific article published on 01 April 1997

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

based on heuristic

inferred from title

high-performance liquid chromatography

1 reference

based on heuristic

inferred from title

author name string

M A Ritter

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C I Furtek

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M W Lo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 April 1997

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Journal of Pharmaceutical and Biomedical Analysis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1021-1029

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

describes a project that uses

high-performance liquid chromatography

1 reference

based on heuristic

inferred from title

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901948-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure effects of the angiotensin II receptor blocker, losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901948-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901948-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901948-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901948-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901948-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0731-7085(96)01948-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9160270%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73357670&oldid=1877391594"